Jove
Visualize
Contact Us

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward Automating the Summarization of Cancer Pathology Reports Using Large Language Models to Improve Clinical Usability.

JCO clinical cancer informatics·2026
Same author

Dosimetric Challenges of Small Lung Lesions in Low-Density Tissue Treated with Stereotactic Body Radiation Therapy.

Journal of clinical medicine·2026
Same author

Valproic acid for treatment of traumatic brain injury: Study protocol for the VIBRANT prospective randomized trial.

Transfusion·2025
Same author

Clinical efficacy of robot-assisted thymectomy for large thymomas: a dual analysis of national and single-institution data.

Journal of thoracic disease·2025
Same author

Methodological Approaches for Measuring the Association Between Heat Exposure and Health Outcomes: A Comprehensive Global Scoping Review.

GeoHealth·2024
Same author

Image-Based Deep Neural Network for Individualizing Radiotherapy Dose Is Transportable Across Health Systems.

JCO clinical cancer informatics·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 17, 2025

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K

Integrative Approaches in Non-Small Cell Lung Cancer Management: The Role of Radiotherapy.

Maxime A Visa1, Mohamed E Abazeed2, Diego Avella Patino1

  • 1Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

Journal of Clinical Medicine
|August 10, 2024
PubMed
Summary

Optimizing non-small cell lung cancer (NSCLC) treatment requires understanding therapy combinations. This review synthesizes prominent NSCLC therapies, highlighting synergistic benefits of combined treatments for improved outcomes.

Keywords:
NSCLCabscopal effectchemoradiotherapyimmunotherapyradiotherapy

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.2K

Related Experiment Videos

Last Updated: Jun 17, 2025

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.7K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.4K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

14.2K

Area of Science:

  • Oncology
  • Medical Therapeutics

Background:

  • Non-small cell lung cancer (NSCLC) treatment guidelines are complex, influenced by stage, patient factors, and treatment goals.
  • The NSCLC therapeutic landscape includes surgery, radiotherapy, chemotherapy, and immunotherapy, with numerous combination possibilities.
  • Optimizing treatment strategies remains a challenge due to the vast number of therapeutic permutations and ongoing evolution of care.

Purpose of the Study:

  • To review and synthesize prominent non-small cell lung cancer (NSCLC) therapies.
  • To explore the interplay and synergistic benefits of combining different NSCLC treatment modalities.
  • To provide insights into optimizing combinatorial therapies for improved patient outcomes.

Main Methods:

  • Literature review and synthesis of existing studies on NSCLC treatment modalities.
  • Comparative analysis of prominent NSCLC therapies, including monotherapies and combinations.
  • Emphasis on identifying and evaluating synergistic effects demonstrated by combinatorial treatments.

Main Results:

  • Various NSCLC treatment modalities, including surgery, radiotherapy, chemotherapy, and immunotherapy, are discussed.
  • Evidence suggests synergistic benefits can be achieved through specific combinations of NSCLC therapies.
  • The interplay between different treatment types offers potential for enhanced efficacy without novel drug development.

Conclusions:

  • Combinatorial therapies hold significant promise for advancing non-small cell lung cancer (NSCLC) treatment.
  • Further research into the synergistic effects of combined NSCLC therapies is warranted.
  • Optimizing treatment through strategic combinations can improve outcomes for patients with NSCLC.